Both are Dividend Kings with decades of consecutive raises, but Medtronic and Abbott reward income investors in fundamentally different ways, and choosing the wrong one in retirement could cost you more than you expect.
Medtronic (MDT) closed at $93.01 in the latest trading session, marking a +1.17% move from the prior day.
Both Medtronic and Abbott have dropped in 2026, and those declines reshuffled the math on yield, valuation, and long-term growth in ways that push retirement investors toward a clear but maybe surprising choice.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Geoffrey Straub Martha CEO | XMIL Exchange | IE00BTN1Y115 ISIN |
| IE Country | 95,000 Employees | 25 Sep 2026 Last Dividend | 27 Sep 1999 Last Split | 13 Jan 1978 IPO Date |
Medtronic plc is a global leader in medical technology, specializing in the development, manufacture, and sale of device-based medical therapies. Serving healthcare systems, physicians, clinicians, and patients around the world, the company is dedicated to alleviating pain, restoring health, and extending life for millions of people. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic operates across various medical domains through its diverse portfolio which includes cardiovascular, medical surgical, neuroscience, and diabetes treatments and technologies.
Medtronic’s comprehensive range of products and services is categorized into four primary segments: